Summary & Overview
CPT 96413: Chemotherapy Administration, Intravenous Infusion Up to One Hour
CPT 96413: Chemotherapy Administration, Intravenous Infusion Up to One Hour
CPT code 96413 is a critical billing code in oncology, representing the administration of chemotherapy through intravenous infusion for up to one hour, covering a single or initial substance or drug. This procedure is a cornerstone of cancer treatment, performed in outpatient hospital infusion centers and physician offices nationwide. The code is widely recognized by major payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage for patients undergoing chemotherapy.
This publication provides a comprehensive overview of CPT 96413, detailing its clinical context, typical sites of service, and its role in the broader landscape of oncology billing. Readers will gain insight into payer coverage, relevant policy updates, and benchmarks for chemotherapy infusion services. The article also highlights related codes and modifiers that distinguish subsequent doses and additional hours of infusion, supporting accurate billing and compliance. With a focus on national standards, the summary equips healthcare professionals, administrators, and policy analysts with essential information to understand the significance and application of CPT 96413 in cancer care.
CPT Code Overview
CPT 96413 is used to report the administration of chemotherapy via intravenous infusion for up to one hour, covering a single or initial substance or drug. This code is central to oncology and infusion medicine, reflecting a common procedure in cancer treatment protocols. Typical sites of service include outpatient hospital infusion centers (such as Place of Service 22) and physician offices (Place of Service 11), where patients receive chemotherapy under medical supervision. The code is essential for accurately documenting and billing the initial hour of intravenous chemotherapy infusion, ensuring proper tracking of clinical services provided in these settings.
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with a malignant neoplasm, such as breast, lung, colon, prostate, or pancreatic cancer, presents to an outpatient hospital infusion center or oncology office for chemotherapy treatment. The provider reviews the patient's medical history and confirms the chemotherapy regimen. The initial intravenous infusion of a single chemotherapy drug is started and monitored for up to one hour. The clinical workflow includes pre-infusion assessment, preparation of the drug, initiation of the IV infusion, monitoring for adverse reactions, and post-infusion documentation. This scenario is typical for patients undergoing scheduled chemotherapy as part of their cancer management plan.
Coding Specifications
- Modifier
EJ: Used to indicate a subsequent dose in a series of the same drug. Do not report an initial dose with theEJmodifier.
| Modifier Code | Description |
|---|---|
EJ | Subsequent Dose in a Series; used to distinguish subsequent doses of the same drug in a sequential series—do not report an initial dose with the EJ modifier. |
- :